Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk³⁴⁸) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML).

Bourgne, Céline

Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk³⁴⁸) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML). [electronic resource] - Leukemia research Mar 2015 - 329-34 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1873-5835

10.1016/j.leukres.2014.11.014 doi


Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Blast Crisis
Child
Chronic Disease
Dasatinib
Disease Progression
Female
Flow Cytometry
Follow-Up Studies
Humans
Intracellular Signaling Peptides and Proteins--genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Middle Aged
Oxazines--pharmacology
Phosphorylation
Prognosis
Protein Kinase Inhibitors--pharmacology
Protein-Tyrosine Kinases--genetics
Pyridines--pharmacology
Pyrimidines--pharmacology
RNA, Messenger--genetics
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
Survival Rate
Syk Kinase
Thiazoles--pharmacology
Tumor Cells, Cultured
Young Adult